VAERS reports by lot

Pfizer COVID-19 lot EWO168: VAERS reports

38 VAERS reports list lot EWO168 as a Pfizer COVID-19 vaccine, received between 2021-05-21 and 2022-06-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
11%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5331%
Cardiac / Cardiovascular3319%
Gastrointestinal2716%
Neurological2213%
Respiratory116%
Musculoskeletal95%
Dermatological (non-injection-site)85%
Allergic / Anaphylactic42%
Thrombotic / Hematological21%
Injection-site / Local reaction21%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
Florida6
Virginia3
New York2
Michigan2
Louisiana2
Tennessee2
North Carolina2
Massachusetts1
Washington1
Illinois1
Puerto Rico1

Reports by month received

2021-053
2021-0610
2021-072
2021-086
2021-097
2021-103
2021-111
2022-022
2022-032
2022-041
2022-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.